Stoke Therapeutics, Inc. (STOK): Shares Outstanding
58.92M
As of 2025-12-31
62.40M
As of 2026-06-30
+14.3%
3-year compound annual growth
+10.0%
5-year compound annual growth
| Period ended | Shares Outstanding | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | 58.92M | +9.0% | 2026-03-16, Balance as of period end |
| 2024-12-31 | 54.03M | +17.7% | 2026-03-16, Balance as of period end |
| 2023-12-31 | 45.92M | +16.4% | 2025-03-18, Balance as of period end |
| 2022-12-31 | 39.44M | +6.9% | 2024-03-25, Balance as of period end |
| 2021-12-31 | 36.90M | +0.9% | 2023-03-06, Balance as of period end |
| 2020-12-31 | 36.58M | +11.3% | 2022-03-10, Balance as of period end |
| 2019-12-31 | 32.86M | n/m | 2021-03-09, Balance as of period end |
| 2018-12-31 | 727.4K | n/a | 2020-03-23, Balance as of period end |